Add Company
Join Now

Vinta Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Employee Data

  • Vinta Bio has 16 Employees.(i)
  • Vinta Bio grew their employee count by 45% last year.

Vinta Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Co-Founder & COOReveal Email/Phone
4
Co-Founder & CTOReveal Email/Phone
5
Chief StaffReveal Email/Phone
6
Head Quality AssuranceReveal Email/Phone
7
Director FacilitiesReveal Email/Phone
8
Director Head Analytical Sciences and TechnologyReveal Email/Phone
9
Director Manufacturing OperationsReveal Email/Phone
10
Sr. Director, Analytical Method DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Vinta Bio?

Vinta Bio, Inc. provides CDMO services in producing GMP-grade and research -grade viral vectors. These vectors include, but are not limited to, AAV and lenti viral vectors. They act as the carrying agents for several disease targets for our customers, which include biotech and pharmaceutical companies and academic research institutes/laboratories.We help deliver customized process development and GMP manufacturing service for cell and gene therapy. This includes every step of the process from start to finish, including:- Research Vector Service- Process Development- Analytical Service- GMP Production- Regulatory SupportOur one-stream process is designed specifically to ensure the consistency you need to meet your needs. Our team of professionals have over three decades of experience in cell and gene therapy.

keywords:N/A

N/A

Total Funding

16

Number of Employees

N/A

Revenue (est)

45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M167%N/A
#2
$2.4M16-6%N/A
#3
$2.6M16-11%N/A
#4
$2.4M1614%N/A
#5
$2.2M16-36%N/A